Using small molecule inhibitors against RIPK1 and or other necroptosis pathway components in a suitable chronic animal model for AD showing neuronal loss would, therefore, provide definitive proof of a role for TNF/TNFR1 stimulated necroptosis in AD. Here, TNFRSF1A is linked to Alzheimer disease.